Back to search

National and Kapodistrian University of Athens

Η S-100B ως δείκτης εγκεφαλικής βλάβης στα νεογνά

Abstract

dc:description

AIMIn this prospective study we evaluated protein S-100B blood levels as a diagnostic and prognosticate biochemcal factor of prematurity, neurological monitoring and outcome in pregnancy and neonates.PATIENTS – METHODSerum S-100B protein was measured in 67 pregnant women just before delivery and in 72 neonates (33 males and 39 females) just after delivery (from umbilicus vein), and 24 hours following delivery (from peripheral vein). S-100B levels were measured by an immuno-luminometric technique with a commercially available kit (Lia-mat Sangtec 100, AB Sangtec Medical). Both monovariant and multivariate analysis were involved in the Statistics.RESULTS – DISCUSSIONSerum S-100B protein in pregnant women found to be significant elevated in preterm labor (p=0.01, univariate analysis). Hypertension (p=0.0443) and other diseases such as epilepsy (p=0.0067), increase S-100B levels in pregnant women, possibly by triggering conditions that lead to premature delivery (multivariate analysis).Serum S-100B protein levels in neonates just after delivery are increased in preterm neonates, impling neural dysfunction (p=0.0023, multivariate analysis). The high Apgar score at min 5, in premature IUGR neonates, possibly due to meticulous resuscitation, is correlated with increased S-100B and it does not exclude any underlying brain injury (p=0.0140, multivariate analysis).Serum S-100B protein levels in neonates 24 hours following delivery imply that intubation, if indicated, is a safe method for protection of brain function (p=0.0095, multivariate analysis). Preterm IUGR neonates had the highest S-100B levels a day post-partum, possibly as a result of peri-natal events that deteriorated brain function following delivery (p=0.0091, multivariate analysis). The mother’s age seems to act protectively on premature brain function (is correlated with lower S-100B levels).The study of serum S-100B variation in neonates, shows that the preterm IUGR neonates (p=0.0068) presented with a more prominent increase in S-100B levels, possibly due to the intense neurological stress following delivery and the incapability of their neural system to adapt fast and satisfactory in the new life circumstances (multivariate analysis). CONCLUSIONSSerum S-100B protein seems to be a reliable biochemical indicator for neurological monitoring in pregnant women and neonates and in particular in preterm and IUGR neonates, during the first days of their life. Consequently, S-100B protein measurements could contribute to prompt therapeutic decisions in order to prevent or even reverse any imminent neurological deterioration in pregnant women or neonates.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Παπαδημητρίου, Αγγελική
  • Papadimitriou, Ageliki

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29330

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Παπαδημητρίου, Αγγελική; Papadimitriou, Ageliki. Η S-100B ως δείκτης εγκεφαλικής βλάβης στα νεογνά. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/29330